Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Transfer of SCN1A to the brain of adolescent mouse model of Dravet syndrome improves epileptic, motor, and behavioral manifestations
Lucia Mora-Jimenez, Miguel Valencia, Rocío Sánchez‐Carpintero, et al.
Molecular Therapy — Nucleic Acids (2021) Vol. 25, pp. 585-602
Open Access | Times Cited: 33

Showing 1-25 of 33 citing articles:

Developmental and epileptic encephalopathies: from genetic heterogeneity to phenotypic continuum
Renzo Guerrini, Valerio Conti, Massimo Mantegazza, et al.
Physiological Reviews (2022) Vol. 103, Iss. 1, pp. 433-513
Open Access | Times Cited: 92
Interneuron-specific dual-AAV SCN1A gene replacement corrects epileptic phenotypes in mouse models of Dravet syndrome
John K. Mich, Jiyun Ryu, Aguan Wei, et al.
Science Translational Medicine (2025) Vol. 17, Iss. 790
Closed Access | Times Cited: 2
Genetic therapeutic advancements for Dravet Syndrome
Ellie Chilcott, Juan Antinao Díaz, Cori Bertram, et al.
Epilepsy & Behavior (2022) Vol. 132, pp. 108741-108741
Open Access | Times Cited: 36
Epilepsy in Dravet Syndrome—Current and Future Therapeutic Opportunities
Chao Gao, Mikolaj Pielas, Fuyong Jiao, et al.
Journal of Clinical Medicine (2023) Vol. 12, Iss. 7, pp. 2532-2532
Open Access | Times Cited: 18
Viral vector–mediated expression of NaV1.1, after seizure onset, reduces epilepsy in mice with Dravet syndrome
Saja Fadila, Bertrand Beucher, Iria G. Dopeso‐Reyes, et al.
Journal of Clinical Investigation (2023) Vol. 133, Iss. 12
Open Access | Times Cited: 16
Are Genetic Therapies for Epilepsy Ready for the Clinic?
James S. Street, Yichen Qiu, Gabriele Lignani
Epiliepsy currents/Epilepsy currents (2023) Vol. 23, Iss. 4, pp. 245-250
Open Access | Times Cited: 13
The expanding field of genetic developmental and epileptic encephalopathies: current understanding and future perspectives
Nicola Specchio, Marina Trivisano, Eleonora Aronica, et al.
The Lancet Child & Adolescent Health (2024) Vol. 8, Iss. 11, pp. 821-834
Closed Access | Times Cited: 5
Embracing the future: Neonatal screening for epileptic syndromes
Rima Nabbout, Mathieu Kuchenbuch
Epilepsia (2025)
Open Access
Utility of adenoviral vectors in animal models of human disease: Genetic diseases
Rubén Hernández-Alcoceba
Elsevier eBooks (2025), pp. 727-753
Closed Access
Gene replacement therapies for inherited disorders of neurotransmission: Current progress in succinic semialdehyde dehydrogenase deficiency
Henry H.C. Lee, Itay Tokatly Latzer, Mariarita Bertoldi, et al.
Journal of Inherited Metabolic Disease (2024) Vol. 47, Iss. 3, pp. 476-493
Closed Access | Times Cited: 4
Regulatory Elements for Gene Therapy of Epilepsy
Ekaterina Chesnokova, Natalia Bal, Ghofran Alhalabi, et al.
Cells (2025) Vol. 14, Iss. 3, pp. 236-236
Open Access
Sex differences in seizure presentation in a Dravet syndrome mouse model
Sheryl Anne D. Vermudez, Rui Lin, Gabrielle E. McGinty, et al.
Neuroreport (2025)
Closed Access
Recent advances and current status of gene therapy for epilepsy
Aojie Cai, Kai Gao, Fan Zhang, et al.
World Journal of Pediatrics (2024) Vol. 20, Iss. 11, pp. 1115-1137
Closed Access | Times Cited: 3
AAV-mediated interneuron-specific gene replacement for Dravet syndrome
John K. Mich, Jiyun Ryu, Aguan Wei, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 7
Clinical and Genetic Features of Dravet Syndrome: A Prime Example of the Role of Precision Medicine in Genetic Epilepsy
Hueng‐Chuen Fan, Ming‐Tao Yang, Lung‐Chang Lin, et al.
International Journal of Molecular Sciences (2023) Vol. 25, Iss. 1, pp. 31-31
Open Access | Times Cited: 7
A tool for Dravet syndrome-associated neuropsychiatric comorbidities evaluation (DANCE)
Simona Giorgi, Stéphane Auvin, An‐Sofie Schoonjans, et al.
Epilepsy & Behavior (2024) Vol. 158, pp. 109958-109958
Open Access | Times Cited: 2
Animal Models of Febrile Seizures: Limitations and Recent Advances in the Field
Alexandra V. Griflyuk, Tatyana Y. Postnikova, Aleksey V. Zaitsev
Cells (2024) Vol. 13, Iss. 22, pp. 1895-1895
Open Access | Times Cited: 2
Heat-induced seizures, premature mortality, and hyperactivity in a novel Scn1a nonsense model for Dravet syndrome
Anat Mavashov, Marina Brusel, Jiaxing Liu, et al.
Frontiers in Cellular Neuroscience (2023) Vol. 17
Open Access | Times Cited: 6
Non-pharmacological therapeutic needs in people with Dravet syndrome
Carla Ballesteros-Sayas, Alicia Muñoz-Montero, Simona Giorgi, et al.
Epilepsy & Behavior (2023) Vol. 150, pp. 109553-109553
Open Access | Times Cited: 5
Phage N15-Based Vectors for Gene Cloning and Expression in Bacteria and Mammalian Cells
Yin Cheng Wong, Allan Wee Ren Ng, Qingwen Chen, et al.
ACS Synthetic Biology (2023) Vol. 12, Iss. 4, pp. 909-921
Open Access | Times Cited: 4
Preferential expression of SCN1A in GABAergic neurons improves survival and epileptic phenotype in a mouse model of Dravet syndrome
Ana Ricobaraza, María Buñuales, Manuela González-Aparicio, et al.
Journal of Molecular Medicine (2023) Vol. 101, Iss. 12, pp. 1587-1601
Open Access | Times Cited: 4
Characterization of brain transduction capability of a BBB-penetrant AAV vector in mice, rats and macaques reveals differences in expression profiles
María Buñuales, Angeles Garduno, Miguel Chillón, et al.
Gene Therapy (2024) Vol. 31, Iss. 9-10, pp. 455-466
Open Access | Times Cited: 1
Investigational new drugs for the treatment of Dravet syndrome: an update
Slobodan Јаnkovic, Snežana V. Janković, Radiša Vojinović, et al.
Expert Opinion on Investigational Drugs (2023) Vol. 32, Iss. 4, pp. 325-331
Closed Access | Times Cited: 2
Gene therapy for Dravet syndrome: promises and impact on disease trigger and secondary modifications
Claudia Di Berardino, Luca Massimino, Federica Ungaro, et al.
Rare Disease and Orphan Drugs Journal (2024) Vol. 3, Iss. 3
Open Access
Genetic and Cellular Mechanisms Underlying SUDEP Risk
Jeffrey L. Noebels
Oxford University Press eBooks (2024), pp. 1338-1346
Closed Access
Page 1 - Next Page

Scroll to top